M
Maibang Bio
An international leading company focusing on the development and production of high-end Chemical Defined media (CD, Chemical Defined) products, optimized development of customized media
About Maibang Bio
MediumBank is a high-tech biotechnology enterprise specializing in integrated solutions for upstream bioprocessing. The company offers a wide range of cataloged media products for various cell lines and provides customized services such as media optimization and development (MOD), cell culture processing development, and original entrusted manufacturing for both dry powder and liquid media. MediumBank also excels in analyzing cell culture supernatants to monitor nutrient consumption and metabolic accumulation, aiding in the regulation of critical quality attributes.
In 2021, MediumBank's MFG1 production facility, built to GMP standards, began operations, and the construction of the MFG2 mass production base is ongoing. The company provides high-quality serum-free media for CHO and other cell lines, supporting the development and commercial production of monoclonal antibodies (mAbs), polyantibodies, and fusion proteins. MediumBank has significant expertise in the XDC field, offering high-performance serum-free media suitable for the development and large-scale production of ADC drugs.
MediumBank serves clients in the biotechnology and pharmaceutical industries, focusing on those involved in cell culture and bioprocessing. The company operates in the global bioprocessing market, leveraging a business model that combines product sales and customized service offerings. Revenue is generated through the sale of cataloged media products, customized media solutions, and specialized bioprocessing services.
Source: Dealroom company dataAt a glance
- Founded
- 2019
- Headquarters
- Jing'an District, China
- Sector
- Consumer Services
News
Open roles
Maibang Bio in the Jing'an District ecosystem
The Maibang Bio office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- NCNeovision Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Maibang Bio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Maibang Bio on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

